Rageot, Denise
39  results:
Search for persons X
?
1

4-(Difluoromethyl)-5-(4-((3R,5S)-3,5-dimethylmorpholino)-6-..:

Borsari, Chiara ; Keles, Erhan ; Rageot, Denise...
Journal of Medicinal Chemistry.  63 (2020)  22 - p. 13595-13617 , 2020
 
?
3

Scalable, Economical, and Practical Synthesis of 4-(Difluor..:

Rageot, Denise ; Beaufils, Florent ; Borsari, Chiara...
Organic Process Research & Development.  23 (2019)  11 - p. 2416-2424 , 2019
 
?
4

A Conformational Restriction Strategy for the Identificatio..:

Borsari, Chiara ; Rageot, Denise ; Dall'Asen, Alix...
Journal of Medicinal Chemistry.  62 (2019)  18 - p. 8609-8630 , 2019
 
?
5

(S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholi..:

Rageot, Denise ; Bohnacker, Thomas ; Keles, Erhan...
Journal of Medicinal Chemistry.  62 (2019)  13 - p. 6241-6261 , 2019
 
?
6

Preclinical Development of PQR514, a Highly Potent PI3K Inh..:

Borsari, Chiara ; Rageot, Denise ; Beaufils, Florent...
ACS Medicinal Chemistry Letters.  10 (2019)  10 - p. 1473-1479 , 2019
 
?
9

Discovery and Preclinical Characterization of 5-[4,6-Bis({3..:

Rageot, Denise ; Bohnacker, Thomas ; Melone, Anna...
Journal of Medicinal Chemistry.  61 (2018)  22 - p. 10084-10105 , 2018
 
?
 
?
14

Proline‐Based P,O Ligand/Iridium Complexes as Highly Select..:

Rageot, Denise ; Woodmansee, David H. ; Pugin, Benoît.
Angewandte Chemie International Edition.  50 (2011)  41 - p. 9598-9601 , 2011
 
1-15